East of England · UK

    Fundraising for Healthtech Startups in Cambridge (2026 Founder's Guide)

    The densest concentration of PhD-founded startups in Europe, dominated by life sciences, semiconductor, and AI research spinouts. For healthtech founders specifically, Healthtech investors want a defined regulatory pathway (UKCA/CE for devices, DTAC for NHS software) and clear evidence of clinical or economic outcomes.

    £1m–£3m

    Typical seed round

    5+

    Active local investors

    East of England

    Region

    Cambridge funding landscape

    Cambridge founders typically raise larger seed rounds because tech risk is higher, expect 12–18 months of runway rather than the London-standard 18–24, and diligence weighted heavily on the science.

    Physical ecosystem hubs where Cambridge founders and investors gather: Cambridge Science Park, Babraham Research Campus, Silicon Fen, The Bradfield Centre. Being visible in these communities remains one of the highest-ROI activities for a first-time founder — most active Cambridge angels get their deal flow from other founders and portfolio companies, not cold outreach.

    What healthtech investors expect

    Healthtech investors want a defined regulatory pathway (UKCA/CE for devices, DTAC for NHS software) and clear evidence of clinical or economic outcomes.

    Benchmarks: NHS pilots signed, published evidence in a peer-reviewed journal, and a reimbursement or procurement pathway mapped out before Series A.

    Reliefs and schemes: SBRI Healthcare, NIHR i4i, and Innovate UK Biomedical Catalyst are the main non-dilutive routes. SEIS/EIS still apply for the software layer.

    Common traps: Assuming NHS pilots convert to paid contracts (they usually don't without a national framework), and under-scoping regulatory costs by 3–5x.

    Active investors in Cambridge for healthtech

    A selection of funds and angel groups currently writing early-stage cheques in Cambridge:

    • Amadeus Capital Partners
    • Cambridge Innovation Capital
    • IQ Capital
    • Cambridge Angels
    • Ahren Innovation Capital

    RaiseAxis's investor database includes 7,000+ UK-active funds and angels with cheque size, sector, and stage filters — plus contact details for members. See how it works.

    Cambridge fundraising by sector

    Healthtech fundraising by city

    Frequently asked questions

    How much can a healthtech startup in Cambridge typically raise at seed?

    Seed rounds in Cambridge for healthtech companies typically land in the £1m–£3m range. Deeptech and healthtech tend to sit at the upper end because capital intensity is higher; SaaS and consumer usually sit at the lower end unless a founder has previously exited.

    Which investors back healthtech companies in Cambridge?

    Active local investors include Amadeus Capital Partners, Cambridge Innovation Capital, IQ Capital, Cambridge Angels, alongside London-based generalist funds. RaiseAxis's 7,000+ investor database filters by sector, cheque size, and geography, so you can shortlist healthtech-active funds active in East of England in minutes.

    What metrics do healthtech investors want to see?

    NHS pilots signed, published evidence in a peer-reviewed journal, and a reimbursement or procurement pathway mapped out before Series A.

    Can I use SEIS or EIS for this round?

    SBRI Healthcare, NIHR i4i, and Innovate UK Biomedical Catalyst are the main non-dilutive routes. SEIS/EIS still apply for the software layer.

    What's the biggest fundraising mistake to avoid?

    Assuming NHS pilots convert to paid contracts (they usually don't without a national framework), and under-scoping regulatory costs by 3–5x.

    Running a raise from Cambridge?

    RaiseAxis gives you the investor CRM, deck analytics, data room, and 7,000+ investor database in one workspace. £1 for 7 days, cancel anytime.

    Start £1 trial